Terrapin Beer Co. Celebrates 23 Years of Craft Beer and Environmental Stewardship with Terraprint Initiative and Orvis Partnership ATHENS, Ga., April 24, 2025 (GLOBE NEWSWIRE) -- a leading craft brewery known for its innovative and high-quality beers and a Tilray Brands, Inc., craft beer brand (NASDAQ: TLRY and TSX: TLRY), is thrilled to partner with , the renowned outdoor retailer and fly-fishing expert. The two companies initially kicked off this partnership in 2024 as part of Terrapin’s initiative, which has objectives to minimize the brewery’s impact on the environment and maximize ...
Merus gibt Annahme von Abstract zur Präsentation auf der ASCO®-Jahrestagung 2025 bekannt - Vorläufige klinische Daten zu Petosemtamab in Kombination mit Pembrolizumab bei 1L PD-L1+ r/m HNSCC für Posterpräsentation ausgewählt - Telefonkonferenz am Donnerstag, 22. Mai, um 17:30 Uhr Eastern Time zur Besprechung des vollständigen ASCO®-Datensatzes UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts, April 24, 2025 (GLOBE NEWSWIRE) -- N.V. (Nasdaq: MRUS) (Merus, das Unternehmen, wir oder unser), ein Onkologieunternehmen, das innovative, multispezifische Volllängen-Antikörper und Anti...
Merus annonce l’acceptation de son résumé pour présentation au congrès annuel 2025 de l’ASCO® - Le pétosemtamab en association avec le pembrolizumab en traitement de première intention d'un CETC r/m PD-L1+ : premières données cliniques provisoires sélectionnées pour une présentation sous forme d’affiche - Conférence téléphonique le jeudi 22 mai à 17 h 30 heure de l’Est (« HE ») pour discuter de l’ensemble de données complet présenté lors de l’ASCO® UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 24 avr. 2025 (GLOBE NEWSWIRE) -- N.V. (Nasdaq : MRUS) (« Merus », la « Société »...
Merus Announces Abstract Accepted for Presentation at the 2025 ASCO® Annual Meeting - Petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC interim clinical data selected for poster presentation - Conference call on Thursday, May 22 at 5:30 p.m. ET to discuss full ASCO® data set UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics®, Triclonics® and ADClonics®), today ann...
Breckenridge Distillery Announces Re-Release of Award-Winning Cognac Cask Finish Whiskey Following a limited release in 2022 for the Collectors Art Series, Breckenridge Cognac Cask Finish Whiskey is now a permanent addition to the cask finish line BRECKENRIDGE, Colo., April 23, 2025 (GLOBE NEWSWIRE) -- , one of the most-awarded craft distilleries in the U.S., and a Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY) spirits brand, today announced its newest addition to the brand’s line of cask finish whiskeys, Breckenridge Cognac Cask Finish. Initially launched as a limited edition in the...
Tilray Beverages Launches Cruisies, a New Line of Ready-To-Drink Cocktails Keep it Cruisie: Enjoy a Taste of the No Frills, Good Life on The East End this Summer NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Beverages, the U.S. beverage division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) announces the introduction of , a new line of refreshing, ready-to-drink cocktails designed to enhance summer vibes. Cruisies' initial product lineup includes: Blood Orange Vodka Soda: The vibrant zest of blood orange is expertly blended with smooth vodka to create a refreshing ...
Tilray Medical Introduces Cannabis Edibles in Australia Tilray Medical Expands Offerings with Good Supply Brand Medical Cannabis Pastilles for Australian Patients SYDNEY, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global company in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, has announced the availability of its medical cannabis edibles, Good Supply Pastilles, to patients in Australia. This launch...
Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders NEW YORK and LEAMINGTON, Ontario, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today announced a special meeting of stockholders (the “Special Meeting”) on June 10, 2025. The Special Meeting will be held via live audio webcast, which can be accessed on the investor page on Tilray.com. At the Special Meeting, ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.